http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2491923-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-529
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2008-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a57ba74d4e5ac4f65e5c78733a07b3a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af9139562bef8d55f951d3b35110d9a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c22ca493a880b185ce8bbfeaa2488aa
publicationDate 2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2491923-A3
titleOfInvention Combinations of therapeutic agents for treating cancer
abstract The invention relates to a combination comprising the N-hydroxy-3-[4-[[[2-(2-methyl-1 H-indol-3-yl)-ethyl]-amino]methyl]phenyl]-2E-2-propenamide; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination.
priorityDate 2007-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007019116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1743654-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226527065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247360797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57519507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226543597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426122635

Total number of triples: 35.